A3A mutations are predominant in many cancer types but surprisingly A3A expression poorly correlates with A3A mutational signature, suggesting that A3A expression is transiently activated, leaving a mutational footprint even after A3A is no longer expressed11,12. Here, APOBEC3A is linked to cancer.